Literature DB >> 30015035

Brain regional synchronous activity predicts tauopathy in 3×TgAD mice.

Dong Liu1, Hanbing Lu2, Elliot Stein2, Zhujuan Zhou3, Yihong Yang2, Mark P Mattson4.   

Abstract

Alzheimer's disease (AD) is characterized by progressive cognitive impairment and by extensive neuronal loss associated with extracellular amyloid β-peptide (Aβ) plaques and intraneuronal tau pathology in temporal and parietal lobes. AD patients are at increased risk for epileptic seizures, and data from experimental models of AD suggest that aberrant neuronal network activity occurs early in the disease process before cognitive deficits and neuronal degeneration. The contributions of Aβ and/or tau pathologies to dysregulation of neuronal network activity are unclear. Using a transgenic mouse model of AD (3×TgAD mice) in which there occurs differential age-dependent development of tau and Aβ plaque pathologies, we applied analysis of resting state functional magnetic resonance imaging regional homogeneity, a measure of local synchronous activity, to discriminate the effects of Aβ and tau on neuronal network activity throughout the brain. Compared to age-matched wild-type mice, 6- to 8-month-old 3×TgAD mice exhibited increased regional homogeneity in the hippocampus and parietal and temporal cortices, regions with tau pathology but not Aβ pathology at this age. By 18-24 months of age, 3×TgAD mice exhibited extensive tau and Aβ pathologies involving the hippocampus and multiple functionally related brain regions, with a spatial expansion of increased local synchronous activity to include those regions. Our findings demonstrate that age-related brain regional hypersynchronous activity is associated with early tau pathology in a mouse model, consistent with a role for early tau pathology in the neuronal circuit hyperexcitability that is believed to precede and contribute to neuronal degeneration in AD. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Amyloid beta peptide; Functional MRI; Hippocampus; Hyperexcitability; Tau

Mesh:

Substances:

Year:  2018        PMID: 30015035      PMCID: PMC6196326          DOI: 10.1016/j.neurobiolaging.2018.06.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  62 in total

1.  Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.

Authors:  Chloe K Nobuhara; Sarah L DeVos; Caitlin Commins; Susanne Wegmann; Benjamin D Moore; Allyson D Roe; Isabel Costantino; Matthew P Frosch; Rose Pitstick; George A Carlson; Christoph Hock; Roger M Nitsch; Fabio Montrasio; Jan Grimm; Anne E Cheung; Anthone W Dunah; Marion Wittmann; Thierry Bussiere; Paul H Weinreb; Bradley T Hyman; Shuko Takeda
Journal:  Am J Pathol       Date:  2017-04-11       Impact factor: 4.307

Review 2.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

3.  Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.

Authors:  Naruhiko Sahara; Jada Lewis; Michael DeTure; Eileen McGowan; Dennis W Dickson; Mike Hutton; Shu-Hui Yen
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

Review 4.  Neuron numbers and dendritic extent in normal aging and Alzheimer's disease.

Authors:  P D Coleman; D G Flood
Journal:  Neurobiol Aging       Date:  1987 Nov-Dec       Impact factor: 4.673

5.  The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.

Authors:  Dong Liu; Michael Pitta; Jong-Hwan Lee; Balmiki Ray; Debomoy K Lahiri; Katsutoshi Furukawa; Mohamed Mughal; Haiyang Jiang; Julissa Villarreal; Roy G Cutler; Nigel H Greig; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Rat brains also have a default mode network.

Authors:  Hanbing Lu; Qihong Zou; Hong Gu; Marcus E Raichle; Elliot A Stein; Yihong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

7.  Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept).

Authors:  Carola Romberg; Mark P Mattson; Mohamed R Mughal; Timothy J Bussey; Lisa M Saksida
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

8.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

Review 9.  Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.

Authors:  Katja Hochgräfe; Astrid Sydow; Eva-Maria Mandelkow
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

Review 10.  Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

Authors:  Stephen W Scheff; Douglas A Price
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

View more
  14 in total

1.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

2.  Orbitofrontal cortex and dorsal striatum functional connectivity predicts incubation of opioid craving after voluntary abstinence.

Authors:  Ida Fredriksson; Pei-Jung Tsai; Aniruddha Shekara; Ying Duan; Sarah V Applebey; Hanbing Lu; Jennifer M Bossert; Yavin Shaham; Yihong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 12.779

3.  Age-related impairment of cerebral blood flow response to KATP channel opener in Alzheimer's disease mice with presenilin-1 mutation.

Authors:  Dong Liu; Ismayil Ahmet; Brandon Griess; David Tweedie; Nigel H Greig; Mark P Mattson
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-17       Impact factor: 6.200

Review 4.  Harnessing the effects of endurance exercise to optimize cognitive health: Fundamental insights from Dr. Mark P. Mattson.

Authors:  Sarah K Jachim; Ayumi E Sakamoto; Xu Zhang; Vesselina M Pearsall; Marissa J Schafer; Nathan K LeBrasseur
Journal:  Ageing Res Rev       Date:  2020-08-16       Impact factor: 10.895

5.  Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer's Disease.

Authors:  Francheska Delgado-Peraza; Carlos J Nogueras-Ortiz; Olga Volpert; Dong Liu; Edward J Goetzl; Mark P Mattson; Nigel H Greig; Erez Eitan; Dimitrios Kapogiannis
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

6.  Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer's Disease.

Authors:  Jangampalli Adi Pradeepkiran; P Hemachandra Reddy
Journal:  Cells       Date:  2019-03-19       Impact factor: 6.600

Review 7.  Amyloid, APP, and Electrical Activity of the Brain.

Authors:  Dimitri Hefter; Susann Ludewig; Andreas Draguhn; Martin Korte
Journal:  Neuroscientist       Date:  2019-11-29       Impact factor: 7.519

8.  Tau deposition is associated with functional isolation of the hippocampus in aging.

Authors:  Theresa M Harrison; Anne Maass; Jenna N Adams; Richard Du; Suzanne L Baker; William J Jagust
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

9.  Prevention of age-associated neuronal hyperexcitability with improved learning and attention upon knockout or antagonism of LPAR2.

Authors:  Johannes Vogt; Irmgard Tegeder; Caroline Fischer; Heiko Endle; Lana Schumann; Annett Wilken-Schmitz; Julia Kaiser; Susanne Gerber; Christina F Vogelaar; Mirko H H Schmidt; Robert Nitsch; Isabel Snodgrass; Dominique Thomas
Journal:  Cell Mol Life Sci       Date:  2020-05-28       Impact factor: 9.261

10.  The Role of Platelets in the Stimulation of Neuronal Synaptic Plasticity, Electric Activity, and Oxidative Phosphorylation: Possibilities for New Therapy of Neurodegenerative Diseases.

Authors:  Ekaterina Kopeikina; Eugene D Ponomarev
Journal:  Front Cell Neurosci       Date:  2021-07-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.